These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

137 related items for PubMed ID: 2353941

  • 1. Growth inhibition by homofolate in tumor cells utilizing a high-affinity folate binding protein as a means for folate internalization.
    Henderson GB, Strauss BP.
    Biochem Pharmacol; 1990 Jun 15; 39(12):2019-25. PubMed ID: 2353941
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Characteristics of a novel transport system for folate compounds in wild-type and methotrexate-resistant L1210 cells.
    Henderson GB, Strauss BP.
    Cancer Res; 1990 Mar 15; 50(6):1709-14. PubMed ID: 2306724
    [Abstract] [Full Text] [Related]

  • 4. Membrane transport of natural folates and antifolate compounds in murine L1210 leukemia cells: role of carrier- and receptor-mediated transport systems.
    Westerhof GR, Jansen G, van Emmerik N, Kathmann I, Rijksen G, Jackman AL, Schornagel JH.
    Cancer Res; 1991 Oct 15; 51(20):5507-13. PubMed ID: 1655252
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Multiple folate transport systems in L1210 cells.
    Fan J, Vitols KS, Huennekens FM.
    Adv Enzyme Regul; 1992 Oct 15; 32():3-15. PubMed ID: 1323205
    [Abstract] [Full Text] [Related]

  • 8. Expression of a folate binding protein in L1210 cells grown in low folate medium.
    Jansen G, Kathmann I, Rademaker BC, Braakhuis BJ, Westerhof GR, Rijksen G, Schornagel JH.
    Cancer Res; 1989 Apr 15; 49(8):1959-63. PubMed ID: 2702638
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Distinguishing between folate receptor-alpha-mediated transport and reduced folate carrier-mediated transport in L1210 leukemia cells.
    Spinella MJ, Brigle KE, Sierra EE, Goldman ID.
    J Biol Chem; 1995 Apr 07; 270(14):7842-9. PubMed ID: 7713875
    [Abstract] [Full Text] [Related]

  • 11. Transport of folate compounds, pterins and adenine in L1210 mouse leukemia cells.
    Huennekens FM, Suresh MR, Vitols KS, Henderson GB.
    Adv Enzyme Regul; 1982 Apr 07; 20():389-408. PubMed ID: 7113803
    [Abstract] [Full Text] [Related]

  • 12. Characterization of folate transport mediated by a low pH route in mouse L1210 leukemia cells with defective reduced folate carrier function.
    Sierra EE, Goldman ID.
    Biochem Pharmacol; 1998 May 01; 55(9):1505-12. PubMed ID: 10076544
    [Abstract] [Full Text] [Related]

  • 13. Identification of a membrane-associated folate-binding protein in human leukemic CCRF-CEM cells with transport-related methotrexate resistance.
    Jansen G, Westerhof GR, Kathmann I, Rademaker BC, Rijksen G, Schornagel JH.
    Cancer Res; 1989 May 01; 49(9):2455-9. PubMed ID: 2706633
    [Abstract] [Full Text] [Related]

  • 14. Functional activity of the reduced folate carrier in KB, MA104, and IGROV-I cells expressing folate-binding protein.
    Westerhof GR, Rijnboutt S, Schornagel JH, Pinedo HM, Peters GJ, Jansen G.
    Cancer Res; 1995 Sep 01; 55(17):3795-802. PubMed ID: 7641196
    [Abstract] [Full Text] [Related]

  • 15. Role for cytosolic folate-binding proteins in the compartmentation of endogenous tetrahydrofolates and the 5-formyl tetrahydrofolate-mediated enhancement of 5-fluoro-2'-deoxyuridine antitumor activity in vitro.
    Matherly LH, Czajkowski CA, Muench SP, Psiakis JT.
    Cancer Res; 1990 Jun 01; 50(11):3262-9. PubMed ID: 2139802
    [Abstract] [Full Text] [Related]

  • 16. Role of methylenetetrahydrofolate depletion in methotrexate-mediated intracellular thymidylate synthesis inhibition in cultured L1210 cells.
    Bunni M, Doig MT, Donato H, Kesavan V, Priest DG.
    Cancer Res; 1988 Jun 15; 48(12):3398-404. PubMed ID: 3370638
    [Abstract] [Full Text] [Related]

  • 17. ICI D1694, a quinazoline antifolate thymidylate synthase inhibitor that is a potent inhibitor of L1210 tumor cell growth in vitro and in vivo: a new agent for clinical study.
    Jackman AL, Taylor GA, Gibson W, Kimbell R, Brown M, Calvert AH, Judson IR, Hughes LR.
    Cancer Res; 1991 Oct 15; 51(20):5579-86. PubMed ID: 1913676
    [Abstract] [Full Text] [Related]

  • 18. A mutated murine reduced folate carrier (RFC1) with increased affinity for folic acid, decreased affinity for methotrexate, and an obligatory anion requirement for transport function.
    Zhao R, Assaraf YG, Goldman ID.
    J Biol Chem; 1998 Jul 24; 273(30):19065-71. PubMed ID: 9668089
    [Abstract] [Full Text] [Related]

  • 19. Transport of folate compounds in L1210 cells: kinetic evidence that folate influx proceeds via the high-affinity transport system for 5-methyltetrahydrofolate and methotrexate.
    Henderson GB, Suresh MR, Vitols KS, Huennekens FM.
    Cancer Res; 1986 Apr 24; 46(4 Pt 1):1639-43. PubMed ID: 3948153
    [Abstract] [Full Text] [Related]

  • 20. Characterization of a human alternatively spliced truncated reduced folate carrier increasing folate accumulation in parental leukemia cells.
    Drori S, Sprecher H, Shemer G, Jansen G, Goldman ID, Assaraf YG.
    Eur J Biochem; 2000 Feb 24; 267(3):690-702. PubMed ID: 10651805
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.